Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 7.96 EUR -0.75%
Market Cap: 222.9m EUR

Intrinsic Value

The intrinsic value of one HYL stock under the Base Case scenario is hidden EUR. Compared to the current market price of 7.96 EUR, Hyloris Pharmaceuticals SA is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

HYL Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Hyloris Pharmaceuticals SA

Intrinsic Value History
Dive into the past to invest in the future

HYL looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if HYL is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about HYL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is HYL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hyloris Pharmaceuticals SA.

Explain Valuation
Compare HYL to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HYL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hyloris Pharmaceuticals SA

Current Assets 24.2m
Cash & Short-Term Investments 19.1m
Receivables 4.6m
Other Current Assets 419k
Non-Current Assets 12.9m
Long-Term Investments 5.1m
PP&E 1.8m
Intangibles 4m
Other Non-Current Assets 2m
Current Liabilities 6.3m
Accounts Payable 2.6m
Other Current Liabilities 3.7m
Non-Current Liabilities 1.8m
Long-Term Debt 1.7m
Other Non-Current Liabilities 148k
Efficiency

Free Cash Flow Analysis
Hyloris Pharmaceuticals SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hyloris Pharmaceuticals SA

Revenue
7.3m EUR
Cost of Revenue
-247k EUR
Gross Profit
7.1m EUR
Operating Expenses
-12.7m EUR
Operating Income
-5.7m EUR
Other Expenses
-744k EUR
Net Income
-6.4m EUR
Fundamental Scores

HYL Profitability Score
Profitability Due Diligence

Hyloris Pharmaceuticals SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
hidden
Profitability
Score

Hyloris Pharmaceuticals SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

HYL Solvency Score
Solvency Due Diligence

Hyloris Pharmaceuticals SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
hidden
Solvency
Score

Hyloris Pharmaceuticals SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HYL Price Targets Summary
Hyloris Pharmaceuticals SA

Wall Street analysts forecast HYL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HYL is 13.84 EUR with a low forecast of 6.06 EUR and a high forecast of 21.42 EUR.

Lowest
Price Target
6.06 EUR
24% Downside
Average
Price Target
13.84 EUR
74% Upside
Highest
Price Target
21.42 EUR
169% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Hyloris Pharmaceuticals SA
does not pay dividends
Shareholder Yield

Current shareholder yield for HYL is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one HYL stock?

The intrinsic value of one HYL stock under the Base Case scenario is hidden EUR.

Is HYL stock undervalued or overvalued?

Compared to the current market price of 7.96 EUR, Hyloris Pharmaceuticals SA is hidden .

Back to Top